Business Context and Reporting Period
This Form 8-K was filed by Healthcare Trust of America, Inc. (NYSE: HTA) and Healthcare Trust of America Holdings, LP on September 22, 2020. The report details corporate actions taken by the Board of Directors regarding shareholder distributions and capital management.
Key Financial Metrics and Capital Actions
- Dividend Increase: The quarterly dividend was increased by 1.59% to $0.320 per share.
- Annualized Yield: The new rate represents an annualized dividend of $1.28 per share, yielding 5.13% based on the September 21, 2020 closing price.
- Dividend Schedule: Payment date is October 9, 2020, for stockholders of record on October 2, 2020.
- Stock Repurchase Program: The Board approved the reactivation and extension of a program to repurchase up to $300 million of Class A common stock.
- Program Expiration: The new program is valid until September 22, 2023, replacing the prior program that expired in August 2020.
- Funding Source: Repurchases will be financed through available cash and the revolving credit facility.
Material Changes Versus Prior Period
The primary material change is the increase in the quarterly dividend rate from the previous level to $0.320 per share. Additionally, the company extended its capital return strategy by renewing the $300 million share repurchase authorization, which had previously lapsed.
Outlook, Risks, and Management Commentary
Management noted that dividend payments are subject to Board discretion and depend on funds available, financial condition, capital expenditure requirements, and REIT distribution requirements. The filing explicitly states that the Board may reduce the dividend rate in the future and that no guarantee is provided regarding future dividend amounts. Stock repurchases are contingent on capital position, market conditions, and legal requirements.
Investor Verification Checklist
- Verify the record date (October 2, 2020) and payment date (October 9, 2020) for the new dividend rate.
- Confirm the total remaining authorization under the new $300 million repurchase program.
- Monitor future filings for actual execution of share repurchases and any changes to the dividend policy.
- Review the company's liquidity position and revolving credit facility usage to assess capacity for both dividends and buybacks.